Healthy volunteers needed to test safety of experimental drug budoprutug
Knowledge-focused
Ongoing
This early-phase study tests the safety of a new drug, budoprutug, in 38 healthy adults aged 18-60. Participants receive either the drug or a placebo by injection or IV. The goal is to check for side effects and how the drug moves through the body, not to treat any disease.
Phase: EARLY_PHASE1 • Sponsor: Climb Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC